Literature DB >> 3410888

Caldesmon: a common actin-linked regulatory protein in the smooth muscle and nonmuscle contractile system.

K Sobue1, K Kanda, T Tanaka, N Ueki.   

Abstract

Caldesmon was originally purified from gizzard smooth muscle as a major calmodulin-binding protein which also interacts with actin filaments. It has an alternative binding ability to either calmodulin or actin filaments depending upon the concentration of Ca2+ ("flip-flop binding"). Two forms of caldesmon (Mr's in the range of 120-150 kDa and 70-80 kDa) have been demonstrated in a wide variety of smooth muscles and nonmuscle cells. Immunohistochemical studies suggest that caldesmon is colocalized with actin filaments in vivo. Considering its abundance, the Ca2+-dependent flip-flop binding ability to either calmodulin or actin filaments, and its intracellular localization, caldesmon is expected to be involved in contractile events. Recent results from our laboratory have led to the conclusion that caldesmon regulates the smooth muscle and nonmuscle actin-myosin interaction and the smooth muscle actin-high Mr actin-binding protein (ABP or filamin) interactin in a flip-flop manner. It might function in cell motility by regulating the contractile system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410888     DOI: 10.1002/jcb.240370306

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  19 in total

1.  A mosaic multiple-binding model for the binding of caldesmon and myosin subfragment-1 to actin.

Authors:  Y D Chen; J M Chalovich
Journal:  Biophys J       Date:  1992-10       Impact factor: 4.033

Review 2.  Vascular smooth muscle contractile elements. Cellular regulation.

Authors:  J T Stull; P J Gallagher; B P Herring; K E Kamm
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

3.  Characterization of the functional properties of smooth muscle caldesmon domain 4a: evidence for an independent inhibitory actin-tropomyosin binding domain.

Authors:  M El-Mezgueldi; O Copeland; I D Fraser; S B Marston; P A Huber
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

4.  Phosphorylation by casein kinase II affects the interaction of caldesmon with smooth muscle myosin and tropomyosin.

Authors:  N V Bogatcheva; A V Vorotnikov; K G Birukov; V P Shirinsky; N B Gusev
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

5.  Location of smooth-muscle myosin and tropomyosin binding sites in the C-terminal 288 residues of human caldesmon.

Authors:  P A Huber; I D Fraser; S B Marston
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

Review 6.  Caldesmon, acidic amino acids and molecular weight determinations.

Authors:  J Bryan
Journal:  J Muscle Res Cell Motil       Date:  1989-04       Impact factor: 2.698

7.  Nitroglycerin inhibits the phosphorylation of intermediate filament proteins rather than myosin light chain on porcine coronary artery sustained contraction.

Authors:  S Ishibashi; K Kawasaki; Y Tate; T Ihara; K Shimada
Journal:  Experientia       Date:  1995-09-29

8.  Contractile elements and myosin light chain phosphorylation in myometrial tissue from nonpregnant and pregnant women.

Authors:  R A Word; J T Stull; M L Casey; K E Kamm
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Caldesmon-phospholipid interaction. Effect of protein kinase C phosphorylation and sequence similarity with other phospholipid-binding proteins.

Authors:  A V Vorotnikov; N V Bogatcheva; N B Gusev
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

10.  Genomic structure of the human caldesmon gene.

Authors:  K Hayashi; H Yano; T Hashida; R Takeuchi; O Takeda; K Asada; E Takahashi; I Kato; K Sobue
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.